Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-26-031924

Chief Financial Officer gave up 180 shares (to pay taxes)

  • Chief Financial Officer acquired 614 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Vu Quan Anh · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-30 Exercise or conversion : show line 1 in the form +614 2,835 D
2026-09-30 Shares withheld for taxes : show line 2 in the form −180 $79.67 $14,341 2,655 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-30 Exercise or conversion : show line 3 in the form Restricted Stock Unit −614 7,984 D
Loading xslF345X06/rdgdoc.xml…